Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood samples
Science Advances · 2025
DOI: 10.1126/sciadv.adt0029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Braelyn Binkowski und 17 weiteren Autor:innen. Beteiligte Einrichtung: Van Andel Institute, Grand Rapids, MI, USA. Hauptthemen laut MEDLINE: Polysaccharides, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Fluorescent Antibody Technique. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) tumor heterogeneity impedes the development of biomarker assays for early disease detection. We hypothesized that PDAC cell subpopulations could be identified by aberrant glycan signatures in both tumor tissue and blood samples. We used multiplexed glycan immunofluorescence to distinguish between PDAC and noncancer cell subpopulations within tumor tissue, and we developed hybrid glycan sandwich assays to determine whether the aberrant glycan signatures could be detected in blood samples. We found that PDAC cells were identified by signatures of glycans detected by four glycan-binding proteins (VVL, CA19-9, sTRA, and GM2) and that there are three types of glycan-defined PDAC tumors: sTRA type, CA19-9 type, and intermixed. In patient-matched tumor and blood samples, the PDAC tumor type could be determined by the aberrant glycans in the blood. As a result, the combined assays of aberrant glycan signatures were more sensitive and specific than any individual assay. Our results demonstrate a methodology to detect and stratify PDAC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Van Andel Institute, Grand Rapids, MI, USA.
- Trinity Health, Grand Rapids, MI, USA.
- University Health Network, Toronto, ON, Canada.
- Department of Laboratory Medicine, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.
- Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden.
- Duke University School of Medicine, Durham, NC, USA.
ORCID-Profile: Braelyn Binkowski, Zachary Klamer, Ben Staal, Maria Blomqvist, Peter Allen, Chanjuan Shi, Aatur Singhi, Randall Brand, Ying Huang, Galen Hostetter, Brian B Haab
Förderung
- NCI NIH HHS
Zitieren
APA
Binkowski, B., Klamer, Z., Gao, C., Staal, B., Repesh, A., Tran, H. L., Brass, D. M., Bartlett, P., Gallinger, S., Blomqvist, M., Morrow, J. B., Allen, P., Shi, C., Singhi, A., Brand, R., Huang, Y., Hostetter, G., & Haab, B. B. (2025). Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood samples. Science Advances. https://doi.org/10.1126/sciadv.adt0029
Vancouver
Binkowski B, Klamer Z, Gao C, Staal B, Repesh A, Tran HL, et al. Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood samples. Science Advances. 2025. doi:10.1126/sciadv.adt0029
BibTeX
@article{Binkowski2025,
author = {Binkowski, Braelyn and Klamer, Zachary and Gao, ChongFeng and Staal, Ben and Repesh, Anna and Tran, Hoang-Le and Brass, David M and Bartlett, Pamela and Gallinger, Steven and Blomqvist, Maria and Morrow, J Bradley and Allen, Peter and Shi, Chanjuan and Singhi, Aatur and Brand, Randall and Huang, Ying and Hostetter, Galen and Haab, Brian B},
title = {Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood samples},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adt0029}
}
EUVIMED